SCHEMBL8867979

SCHEMBL8867979

COCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2cccc(C(=O)NCCc3ccc(Cl)cc3)c2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.49
AKR1C3 P42330 1/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.44
GAA P10253 2/20 0.44
HTT P42858 1/20 0.44
P4HTM Q9NXG6 1/20 0.44
NAMPT P43490 1/20 0.44
EGFR P00533 1/20 0.44
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
PSEN1 P49768 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868537 0.92 RAB9A (0.45) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL9140238 0.92 PPARA (0.49) PPARAAKR1C3MAPTMEN1KMT2A
SCHEMBL8868797 0.92 SMN1; SMN2 (0.49) PPARAMAPTMEN1KMT2ANPC1
SCHEMBL8869533 0.92 PPARA (0.49) PPARAAKR1C3MAPTMEN1KMT2A
SCHEMBL8869195 0.91 MAPT (0.50) PPARAAKR1C3MAPTNPC1RAB9A
SCHEMBL8869085 0.91 P4HTM (0.52) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL8869577 0.90 EGFR (0.53) PPARAMAPTMEN1KMT2ANPC1
SCHEMBL8869604 0.90 EGFR (0.53) PPARAMAPTMEN1KMT2ANPC1
SCHEMBL7874565 0.90 PPARA (0.46) PPARAAKR1C3MAPTMEN1KMT2A
SCHEMBL9140459 0.89 P4HTM (0.57) PPARAAKR1C3MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed